Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates For The Next Quarter

Share:
Related ABAX
Canaccord Believes Zoetis Could Bid For Idexx Laboratories
Medtronic Has Big Plans For This Device (And It Could Help 500,000 People Each Year)
Should You Buy Evolving Trends in Medical Devices? - Industry Outlook (Zacks)
Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS
Healthcare Dividend Dogs: 3% To 10% Yields From Top 10 As Of July 29 (Seeking Alpha)

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.

Abaxis (NASDAQ: ABAX) is estimated to post earnings of $0.24 per share in the June quarter. Abaxis' trailing-twelve-month revenue is $178.79 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.22 per share in the June quarter. Meridian Bioscience's trailing-twelve-month operating margin is 29.72%.

SurModics (NASDAQ: SRDX) is likely to earn $0.22 per share in the June quarter. SurModics had $30.96 million in total cash for the latest quarter.

Trinity Biotech plc (NASDAQ: TRIB) may earn $0.20 per share in the March quarter. Trinity Biotech's PEG ratio is 1.88.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-cap stocksTrading Ideas

 

Related Articles (ABAX + SRDX)

Get Benzinga's Newsletters